CLINICAL_TRIALS
trial_result
· 2023-09-28
Clinical Trial Update: Beta Blocker Use In Traumatic Brain Injury Based On The High-Sensitive Troponin T Status [Phase 4]
Summary
Phase 4 trial update evaluating beta blocker use in traumatic brain injury stratified by high-sensitivity troponin T status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Hamad Medical Corporation | Conditions: Trauma, Brain Injuries | Phase 4 | Status: UNKNOWN